Related Experiment Video
Updated: Jun 21, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The uremic retention solute p-cresyl sulfate and markers of endothelial damage
Björn K I Meijers1, Soetkin Van Kerckhoven, Kristin Verbeke
1Department of Medicine, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium.
Insights
In hemodialysis patients, the uremic toxin p-cresyl sulfate is linked to endothelial microparticle shedding. This suggests p-cresyl sulfate contributes to endothelial dysfunction in chronic kidney disease patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Toxicology
Background:
- Cardiovascular disease is a major concern for chronic kidney disease patients.
- The uremic retention solute p-cresol is linked to cardiovascular disease in hemodialysis patients.
- Mechanisms linking p-cresol to cardiovascular disease remain unclear.
Purpose of the Study:
- To investigate the association between p-cresol and markers of endothelial dysfunction in hemodialysis patients.
- To determine the direct effects of p-cresol and its derivative p-cresyl sulfate on endothelial cells in vitro.
Main Methods:
- Prospective observational study of 100 hemodialysis patients.
- In vitro experiments using human umbilical vein endothelial cells.
- Measured serum p-cresol, p-cresyl sulfate, soluble P-selectin, and endothelial microparticles.
Main Results:
- Free serum p-cresol correlated with circulating endothelial microparticles in patients.
- p-Cresyl sulfate induced dose-dependent shedding of endothelial microparticles in vitro.
- Rho kinase inhibition blocked p-cresyl sulfate-induced microparticle shedding.
Conclusions:
- p-Cresyl sulfate promotes endothelial microparticle shedding, suggesting a role in endothelial dysfunction in hemodialysis patients.
- The in vitro findings indicate p-cresyl sulfate alters endothelial function independently of overt damage.
- Further mechanistic studies are needed to explore the in vivo relationship.
Background:
Cardiovascular disease is highly prevalent in patients with chronic kidney disease. In hemodialysis patients, the protein-bound uremic retention solute p-cresol is independently associated with cardiovascular disease. The underlying mechanisms have not been elucidated.
Study Design:
(1) Prospective observational study of humans and (2) in vitro study in human umbilical vein endothelial cells.
Setting:
Hemodialysis patients.
Factor:
p-Cresol and its main derivative p-cresyl sulfate.
Outcomes:
Endothelial dysfunction.
Measurements:
We studied: (1) the relation between p-cresol and blood markers of endothelial dysfunction, including soluble P-selectin and endothelial microparticles; and (2) direct effects of p-cresol and p-cresyl sulfate on endothelial cell cultures.
Results:
(1) In a cohort of 100 maintenance hemodialysis patients, free serum p-cresol concentrations (median, 11.7 micromol/L; interquartile range, 15.2) were directly associated with circulating endothelial microparticles (P = 0.007), but not with soluble P-selectin (mean, 37.7 +/- 14.4 [SD] pg/mL). Other independent determinants of the degree of circulating microparticles were greater serum phosphorus (mean, 4.8 +/- 1.5 mg/dL; P = 0.008) and serum calcium concentrations (mean, 9.3 +/- 0.8 mg/dL; P = 0.03), whereas treatment with active vitamin D (P = 0.008) and vintage (median, 25 months; P = 0.04) were inversely associated. (2) In vitro, p-cresyl sulfate induced a dose-dependent increase in the shedding of endothelial microparticles (P < 0.001) by human umbilical vein endothelial cells. Shedding was reduced, but not completely aborted, in the presence of albumin, whereas the selective Rho kinase inhibitor Y-27632 abrogated the p-cresyl sulfate-induced generation of endothelial microparticles.
Limitations:
The relationship between p-cresyl sulfate and shedding of endothelial microparticles in vivo was not mechanistically explored.
Conclusion:
p-Cresyl sulfate induces shedding of endothelial microparticles in the absence of overt endothelial damage in vitro and is independently associated with the number of endothelial microparticles in hemodialysis patients. These findings suggest that p-cresyl sulfate alters endothelial function in hemodialysis patients.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Urine Studies I: Urinalysis
Chronic Kidney Disease II: Clinical Manifestations
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention

